ARCHIVES

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

This article is from The Cancer Letter archive.

Vol. 39 No. 07 | February 15, 2013

Download PDF Visit The Full Archive

Related Articles

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

NCI Grants: UT Southwestern, M.D. Anderson Win Lung Cancer SPORE

December 6, 1996

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

NCI To Hold Symposium To Honor Wener Kirsten

April 2, 1993